Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Multilingual Version of ForceLogix Sales Performance Suite Available
ForceLogix Leads the Market in Offering Multi-Lingual Sales Performance Management and Optimization Capabilities. - June 24, 2008 - ForceLogix
LegalView Launches PAGCL Practice Area for Victims with Cartilage Deterioration Following Arthroscopic Shoulder Surgery
LegalView launched a PAGCL information portal to provide victims of the condition with resources and details on protective and preventive measures and information. Post arthroscopic glenohumeral chondrolysis (PAGCL) occurs when the cartilage in a shoulder begins to deteriorate months after arthroscopic shoulder surgery. - June 24, 2008 - LegalView
Xcelience Strengthens Development Services with Addition to Executive Team
The formulation development company’s services are led by an industry pioneer. - June 22, 2008 - Xcelience, LLC
Anavex Further Strengthens Board of Directors
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced the appointment of David L. Tousley, CPA, MBA, to its Board of Directors. Mr. Tousley is an accomplished professional with many years of experience as a senior financial and operations executive in start-up and... - June 20, 2008 - Anavex Life Sciences Corp.
New Pressure Sensor: High Quality Pressure Solution Starting at €97
FUTEK Advanced Sensor Technology, Inc has expanded its Pressure Sensor product line yet again by adding the new model: Pressure Sensor PMP300 to its line up. This marks the second pressure sensor release for FUTEK in 2008. The PMP300 Pressure Sensor (OEM) is precision engineered and manufactured to... - June 19, 2008 - FUTEK Advanced Sensor Technology, Inc.
Multipurpose PVC Tubing Now Stocked in Over 50 Sizes; Suitable for Fluid & Air Transfer, More
NewAge(R) Industries now offers its PVC tubing, Clearflo(R), in more than 50 sizes from 1/16” to 4” I.D. Clearflo is used for liquid transfer, air lines, and jacketing in both clean and industrial applications. The compound meets USP Class VI, FDA, 3A, and NSF standards and provides rubber-like flexibility. Clearflo withstands a wide range of chemicals and corrosive fluids and handles temperatures up to 175°F (79.4°C). Its smooth surface resists bacteria and sediment buildup. - June 18, 2008 - NewAge Industries, Inc.
RNCOS Releases a New Report- Indian Contract Manufacturing - A Hot Opportunity
RNCOS new Market Research Report titled, "Indian Contract Manufacturing - A Hot Opportunity" gives first hand information on the thriving and growing trends in the Indian pharma market. - June 14, 2008 - RNCOS
Senior Director of Biotherapeutics at Xencor Will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
David Szymkowski, Senior Director of Biotherapeutics at Xencor will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA - June 13, 2008 - GTCbio
Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
Kanji Takada, Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. - June 13, 2008 - GTCbio
Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. - June 13, 2008 - GTCbio
VP of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
Paul Watt, Vice President of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. - June 13, 2008 - GTCbio
Chinese Drug Market Jumped 19% in 2007 to US$50 Bln - WiCON Launches China Pharmaceutical Guide 2008 (3rd Edition)
WiCON International Group, the publisher of Pharma China, announced the official publication of its China Pharmaceutical Guide 2008 (3rd Edition). According to latest estimates by WiCON in this annually-updated Guide, the size of the Chinese drug market (including all Western and traditional... - June 10, 2008 - WiCON International Group LLC
Police Respond to a Sonitrol Pacific Emergency Alert, Arrest One
Police apprehended an individual suspected of trying to get drugs with a fake prescription from a Sonitrol Pacific protected pharmacy after pharmacy employees pressed an emergency alert button June 2. A highly trained Sonitrol Pacific operator received the emergency alert, or “panic”... - June 08, 2008 - Sound Security, Inc., dba Sonitrol Pacific
RNCOS Releases a New Report- Emerging Pharmaceutical Markets Globally
RNCOS has recently added a new Market Research Report titled, "Emerging Pharmaceutical Markets Globally" to its report gallery. This Report provides a detailed account of the factors that are redefining the structure and composition of the global pharmaceutical market and causing a shift... - June 08, 2008 - RNCOS
LegalView Updates Levaquin Practice Area with New Side Effect Information on Severe Tendon Rupture Among Patients
LegalView recently updated its Levaquin information portal with new information pertaining to the dangerous side effects that may be causing tendon ruptures among patients. Levaquin, an antibiotic used to treat bacterial infections, has been linked to spontaneous tendon rupture among patients as well as other side effects. - June 02, 2008 - LegalView
LegalView Announced Its Newest Information Portal with Details of the Digitek Digoxin Heart Tablet Recall
LegalView informed readers of its newest information portal detailing the U.S. Food and Drug Administration (FDA) ordered recall of the Digitek-brand digoxin heart tablets. The tablets may have been manufactured containing twice the amount of active ingredient approved. - May 28, 2008 - LegalView
Commercial Insight - CNS Market Overview - Commercial Dynamics and Outlook of the Neurology, Pain and Psychiatry Market Sectors
The market for CNS drugs across the 7MM was worth a substantial $95.5 billion, accounting for a 21.4% share of the total pharmaceutical market value in 2007. - May 27, 2008 - companiesandmarkets.com
Xcelience and Its CEO Are Finalists for Three Prestigious Business Awards
The Tampa-based CRO and its chief executive are voted as best company and CEO of the year. - May 26, 2008 - Xcelience, LLC
Trace Contaminant Detection by Ultraviolet Microscopy and Microspectroscopy
Detection and analysis of trace organic and inorganic contaminants on precision devices by ultraviolet microscopy and microspectroscopy. - May 23, 2008 - CRAIC Technologies, Inc.
Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management
Anavex Life Sciences Corp. ("ANAVEX'') (OTC BB:AVXL.OB) today announced the appointment of Alison Ayers to its Board of Directors. Ms. Ayers is currently the Worldwide Commercial Head for Oncology at Pfizer, with responsibility for Pfizer's oncology portfolio, which includes more than 20 drug... - May 23, 2008 - Anavex Life Sciences Corp.
Integrated Service Solutions, Inc. Celebrates 10 Years in Business
Largest independent services provider celebrates ten years of servicing the pharmaceutical, biotechnology and medical device sectors. - May 15, 2008 - Integrated Service Solutions, Inc.
Generics to Capture 23% Pharmaceutical Market in Brazil by 2011
With big government support, generics is expected to occupy 23% of total Brazilian pharmaceutical market by 2011 and will emerge as one of the largest generics markets in the world, predicts RNCOS. - May 09, 2008 - RNCOS
Singaporean Market as Big Potential for Hovid
With the launch of Hovid’s new online store, hovid.sg, the premium products Hovid was recognized for will be made even more popular. The Singaporean market is seen as having big potential in terms of online users purchasing through the web, especially those engaged in the pharmaceutical industry. - May 08, 2008 - Hovid
Xcelience Launches New Service to Enhance Its Preformulation & Formulation Capabilities
The Tampa-based CRO continues its perpetual growth with new XRD support. - May 08, 2008 - Xcelience, LLC
LegalView Reports on Details of FDA Warning to Avandia Manufacturer for Withholding Avandia Study Research
LegalView recently reported the FDA warning letter given to manufacturers of Avandia for withholding post-market research. GlaxoSmithKline failed to comply with FDA regulations and offer officials full details of 10 ongoing clinical trials. - May 07, 2008 - LegalView
Medical Writers Convene in Indianapolis This June for Documentation and Training Life Sciences 2008 Conference
Medical, science, and marketing writers, and health care information technologists, will convene in downtown Indianapolis this June at the Documentation and Training Life Sciences Conference (http://www.doctrain.com/life) to explore ways to reduce the amount of time and energy it takes to create... - May 03, 2008 - Documentation and Training Life Sciences
LegalView Updates Its Baxter Heparin Information Portal with News of Ongoing United States and China Heparin Contamination Controversy
LegalView recently updated its Heparin information portal on the latest news regarding the contaminated batch of Heparin, which may have sickened hundreds and caused the death of up to 90 individuals. U.S. officials have sourced the contamination to a manufacturing plant in China, but Chinese officials insist the contamination occurred in the United States. - April 30, 2008 - LegalView
ISO 11607 Compliance Ensured with Reintroduction of Webinar Series
Critical ISO 11607 clause 6 compliance questions answered in three chapter webinar series - April 24, 2008 - DDL Inc.
AdvantaPure(R) Introduces a New Tubing That’s Weldable, Heat Sealable and Offers Great Pump Life
AdvantaFlex(TM) is a new tubing developed by AdvantaPure for biopharmaceutical and critical fluid processing applications. It's flexible, may be heat sealed for sampling uses or welded, and is specially formulated to perform better than other materials in peristaltic pumps. Made from biopharmaceutical-grade TPE (thermoplastic elastomer), AdvantaFlex offers low permeability and withstands repeated compression and release for consistent, dependable performance. - April 11, 2008 - NewAge Industries, Inc.
Plymouth Pharmaceuticals and Dermatologist Cited in ‘Skin and Allergy News’ Regarding Drug’s (Acunol™) Role in Preventing Jewelry Allergy
The respected journal “Skin & Allergy News” recently released “Nickel Named Contact Allergen of the Year” in its current issue. Researcher Dr Katherine A Zug, of the Department of Dermatology at Dartmouth Hitchcock Medical Center in Lebanon, NH, has published her... - April 10, 2008 - Plymouth Pharmaceuticals Inc
RNCOS Releases Report on Generic Drug Market in Canada
Canada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. Generics in 2007 accounted for more then 46% prescriptions and 19% sales out of the total pharmaceutical market. The market is currently being driven by several factors, such as patent... - April 06, 2008 - RNCOS
LegalView Updates Singulair Practice Area with Additional Information on Link Between the Drug and Increased Suicide Risk
LegalView recently amended its Singulair information portal after reports to the U.S. Food and Drug Administration (FDA) linked the allergy drug and to an increased risk of suicide among patients. Singulair is prescribed to treat asthma as well as allergy symptoms such as sneezing and stuffy nose and is used by thousands of Americans. - April 05, 2008 - LegalView
CureHIV Seeks Funding for LiSAVIOR from Bill and Melinda Gates' Grand Challenges to Cure HIV
Dr. Roger Kenneth Hershline PhD MD, Global Humanceuticals, Inc and CureHIV apply to Bill and Melinda Gates' Grand Challenges in Global Health to fund the new HIV non-traditional drug LiSAVIOR. Current drug and vaccination treatments do not treat the growth of HIV in the gastrointestinal tract. - April 02, 2008 - CureHIV
LegalView Expands Baxter Heparin Information Portal to Include Information on an Additional Heparin Recall
LegalView updated its Baxter Heparin information portal to add information on the most recent recall of the blood-thinning drug. Heparin, which is used to control blood during surgical procedures, was recently discovered to have a Heparin-like contaminant that sickened many and caused at least 19 deaths. - April 01, 2008 - LegalView
Avanti Therapeutics Launches Chikujee Therapeutics, a Targeted Drug Delivery Company
Avanti Therapeutics, a privately held biopharmaceutical company, said it has incubated and launched a new bionanotechnology company for targeted drug delivery called Chikujee Therapeutics. Chikujee Therapeutics hopes to commercialize nanomedicines using its proprietary, cell specific targeted drug... - March 28, 2008 - Chikujee Therapeutics
Announcing the Launch of RealHealthSavings.com
Announcing the launch of RealHealthSavings.com: a free resource to access major savings on drugs and other medical needs. - March 25, 2008 - Real Health Savings LLC
National Courses Taught by Former FDA Investigators Examine Latest Strategies for Integrating Quality and Risk Management
A series of FDA compliance training courses taught by former FDA investigators will examine the regulations and best practices for integrating quality and risk management. Courses will be held in Charlotte, NC, and Providence, RI. - March 24, 2008 - EduQuest Inc.
LegalView Updates Baxter Heparin Portal with Information on the Source of Contamination for the Recalled Blood-Thinning Drug
LegalView updated its readers on the latest Baxter Heparin news from the FDA, which discovered the source of contamination of the blood-thinning agent to be a Chinese manufacturer. An investigation is underway to determine if the manufacturer intentionally compromised the safety of patients by using a less expensive derivative in the injectable drug. - March 23, 2008 - LegalView
GTCbio Announces Its 4th Modern Drug Discovery and Development Summit Taking Place on October 15-17, 2008 in San Diego, CA
GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA. Now in its fourth year, the summit will once again provide a landscape and in-depth industry analysis streaming through different therapeutic and target areas and examining the current advancements and where we’re headed in the coming years. - March 23, 2008 - GTCbio
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
First New Agent for CLL Patients Approved by the FDA since 2001 - March 21, 2008 - Cephalon
Biopharma Innovators Syntaxin Wins Top Honours at 2007 Interactive Media Awards
Biopharma firm Syntaxin's new website has won a very prestigious IMA award which recognises great design, technical innovation and accessibility compliance within the interactive media industry. - March 19, 2008 - Syntaxin Ltd
RNCOS Releases Report on Indian Pharma Sector Analysis
The market research report “Indian Pharma Sector Analysis” by RNCOS is detailed study of the Indian pharmaceutical market. - March 17, 2008 - RNCOS
LegalView is Proud to Announce the Launch of New FDA Notification Service
LegalView recently launched its U.S. Food and Drug Administration (FDA) notification service, which will allow individuals suffering from negative pharmaceutical side effects to voice their concerns directly to the FDA. LegalView currently offers a vast plentitude of practice areas relating to adverse pharmaceutical side effects but now readers will be able to take immediate action. - March 15, 2008 - LegalView
SecureRF to Present “What Do We Really Mean by Security for RFID -- And How Much is Enough” at INTERPHEX 2008 Pharmaceutical Conference
Louis Parks, CEO of SecureRF, to Present “What Do We Really Mean By Security for RFID -- And How Much Is Enough” on March 26, 2008 at 2 PM at INTERPHEX 2008 pharmaceutical conference in Philadelphia. Parks to detail RFID Security functions for pharmaceutical applications. - March 14, 2008 - SecureRF Corporation
Safety Stressed in Updated Guidance on Methadone for the Relief of Chronic Pain
Essential guidance for practitioners on safely prescribing methadone for patients with chronic pain, along with special instructions for patients on how to avoid methadone adverse events or overdose, are available in two new documents exclusively from Pain Treatment Topics. - March 13, 2008 - Pain Treatment Topics
NCSRT Launches DiaSync for Improved Yield, Lower Cost in Harvest, Concentration, and Diafiltration of Biomolecules
At the Antibody Development and Production meeting in San Diego, CA March 12, 2008, NCSRT is launching its DiaSync process for biomolecules from fermentation, cell culture, or extraction. Utilizing concurrent processing technology and the patented SmartFlow™ TFF technology, DiaSync provides... - March 12, 2008 - NCSRT, Inc.
Basel Life Forum Launches on BioValley.ch with Partner glocals.com; Win iPhone
BioValley.ch announces the launch of Basel Life in partnership with glocals.com, which offers forums and networking platforms in several cities and regions in Switzerland. Basel Life targets a business and academic audience, which is interested in sharing Best Business Practices, strengthening... - March 09, 2008 - BioValley.ch
Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18
Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA - March 08, 2008 - GTCbio
Life is Good RX Announces Free Prescription Plan
The Life is Good Rx program will provide on the spot price reductions of up to 75% percent on commonly used prescription drugs. Any resident of the United States is eligible to receive a card, it is completely free of charge and there are no burdensome qualification criteria or application processes. Savings are calculated instantly at the time of purchase. - March 07, 2008 - Life is Good Prescription Plan
FDA Approves Pristiq for the Treatment of Adult Patients with Major Depressive Disorder
The FDA has approved PRISTIQ (desvenlafaxine), an SNRI, to treat adult patients with major depressive disorder (MDD). Wyeth expects to begin shipping PRISTIQ to wholesalers beginning in the second quarter of 2008. - March 01, 2008 - Wyeth Pharmaceuticals